Expert Reviews in Molecular Medicine launches ‘Discovery’ section
14 July 2014
Last update: 14/07/14 11:46
Expert Reviews in Molecular Medicine launches ‘Discovery’ section and welcomes original research under a gold Open Access extension.
We have launched the ‘Discovery’ section within our journal Expert Reviews in Molecular Medicine (ERMM) and now welcome high-quality, innovative original research papers to complement its authoritative ‘Reviews’ section. Authors who wish to publish their papers in ‘ERMM: Discovery’ will be able to do so under a gold Open Access model and payment of an article processing charge (APC). Reviews will continue to be accessed via a subscription to ERMM, with Open Access as an option for Review authors to choose should they wish to pay the APC.
ERMM has been publishing high-quality peer-refereed review articles since late 1997, which have proved a valuable forum for authoritative reviews in the area of molecular medicine. The Journal has an impressive Impact Factor of 6.628 (2012), which places it in a strong position amongst its competitors and this expansion will provide readers and authors with an enhanced resource for molecular medicine research.
ERMM: Discovery will be overseen and edited by Dr Julian Sale who will be working alongside the Editor-in-Chief, Professor Timothy Cox.
“We are delighted that Cambridge University Press has decided to enrich its portfolio of contemporary biological science by taking this publication initiative; it will incorporate new pages of experimental research to synergise with Expert Reviews. We welcome this innovative step and greatly look forward to receiving fresh discovery science in molecular medicine for competitive publication.”
Molecular medicine as a broad definition refers to elucidating the pathogenesis of disease at the molecular or physiological level, which may lead to the design of specific tools for disease diagnosis, treatment or prevention – this highlights the timeliness and importance of the Journal in the field. ERMM: Discovery will publish original work from across the full breadth of molecular medicine and pathology. Its scope mirrors that of ERMM: Reviews focussing on the molecular mechanisms of disease, diagnostics and therapy. The Journal particularly invites original research papers which provide mechanistic insights, while papers of a purely descriptive or correlative nature and case reports are unlikely to be accepted unless they provide exceptional scientific insight.
The Editors are inviting high-quality contributions of original research for ERMM: Discovery and review papers for ERMM: Reviews. For detailed instructions on how to prepare your submission, please see our Instructions for Contributors.
Content from Expert Reviews in Molecular Medicine can be viewed at journals.cambridge.org/erm. A subscription will be required to access Review articles but all Discovery articles will be freely available under an OA license and are not included in the subscription price. All Open Access articles in this journal have article level metrics available.
Related Posts
International Women’s Day 2020: Influential women in STEM
International Women’s Day 2020 falls on Sunday, 8th March this year. In the run up to this date, each week day we’ll be highlighting one woman whose accomplishments in science, technology, engineering and/or mathematics not only elevated their fields but also took us one step closer to a gender-equal world. We hope you’ll join us […]
Where Physical and Digital Worlds Collide
In this blog for Data-Centric Engineering, Paul Clarke (Chief Technology Officer at Ocado) documents Ocado’s journey with building synthetic models of its business, its platforms and its underlying technologies, including the use of simulations, emulations, visualisations and digital twins. He explores the potential benefits of digital twins, including the opportunities for creating digital twins at […]
Wisconsin’s Response to the Coronavirus Pandemic – Now updated
From time to time, until the crisis has passed, the HEPL blog series authors will be given the opportunity to provide short updates on their country/region’s continuing response to this worldwide catastrophe and their further reflections on those responses. Each update will be labelled accordingly with the original response at the bottom of each post. […]
Government’s flagship Welfare-to-Work scheme – failing the ‘harder to help’ by design?
The Work Programme is Government’s flagship welfare-to-work initiative and uses non-state providers to support long-term unemployed people into paid employment under a payment by results funding regime. Within such quasi-marketised systems the problem of inequitable and/or inadequate treatment of claimants with multiple or complex needs (typically referred to as ‘parking’) is notoriously pervasive and difficult […]
;
